Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Thomas

Blood

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Blood|November 11, 2021
Machine learning finds new AML subtypesDaniel Thomas
Blood|February 5, 2017
Biology and relevance of human acute myeloid leukemia stem cellsDaniel Thomas, Ravindra Majeti
Blood|May 14, 2009
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in diseaseTimothy R Hercus, Daniel Thomas, Mark A Guthridge, et al.
Blood|November 16, 2014
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibitionSubarna Sinha, Daniel Thomas, Linda Yu, et al.
Blood|June 26, 2020
The 14-3-3ζ-c-Src-integrin-β3 complex is vital for platelet activationChuanbin Shen, Ming Liu, Runjia Xu, et al.
Blood|August 30, 2022
Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitudeMeiquan Li, Xiaopeng Tang, Zhiyi Liao, et al.
Blood|December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemiaJason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Blood|October 7, 2009
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AMLJason A Powell, Daniel Thomas, Emma F Barry, et al.
Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.
Blood|November 20, 2014
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formationAndreas Reinisch, Nathalie Etchart, Daniel Thomas, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Blood|November 11, 2021
Machine learning finds new AML subtypesDaniel Thomas
Blood|February 5, 2017
Biology and relevance of human acute myeloid leukemia stem cellsDaniel Thomas, Ravindra Majeti
Blood|May 14, 2009
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in diseaseTimothy R Hercus, Daniel Thomas, Mark A Guthridge, et al.
Blood|November 16, 2014
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibitionSubarna Sinha, Daniel Thomas, Linda Yu, et al.
Blood|June 26, 2020
The 14-3-3ζ-c-Src-integrin-β3 complex is vital for platelet activationChuanbin Shen, Ming Liu, Runjia Xu, et al.
Blood|August 30, 2022
Hypoxia and low temperature upregulate transferrin to induce hypercoagulability at high altitudeMeiquan Li, Xiaopeng Tang, Zhiyi Liao, et al.
Blood|December 14, 2016
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemiaJason A Powell, Alexander C Lewis, Wenying Zhu, et al.
Blood|October 7, 2009
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AMLJason A Powell, Daniel Thomas, Emma F Barry, et al.
Blood|January 2, 2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib SensitivityChloe Al Thompson-Peach, Daniel Thomas, Mara Dottore, et al.
Blood|November 20, 2014
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formationAndreas Reinisch, Nathalie Etchart, Daniel Thomas, et al.
Pageof 2